Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hanley

Showing results (411-420 of 436) with videos related to

Pageof 44
Sort By:
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Neurological Research and Practice|December 16, 2020
The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trialU Meyding-Lamadé, C Jacobi, F Martinez-Torres, et al.
Science Immunology|April 23, 2021
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhageMichael H Askenase, Brittany A Goods, Hannah E Beatty, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.
Neurocritical Care|June 25, 2020
The Curing Coma Campaign: Framing Initial Scientific Challenges-Proceedings of the First Curing Coma Campaign Scientific Advisory Council MeetingJ Javier Provencio, J Claude Hemphill, Jan Claassen, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Pageof 44

Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Neurological Research and Practice|December 16, 2020
The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trialU Meyding-Lamadé, C Jacobi, F Martinez-Torres, et al.
Science Immunology|April 23, 2021
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhageMichael H Askenase, Brittany A Goods, Hannah E Beatty, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.
Neurocritical Care|June 25, 2020
The Curing Coma Campaign: Framing Initial Scientific Challenges-Proceedings of the First Curing Coma Campaign Scientific Advisory Council MeetingJ Javier Provencio, J Claude Hemphill, Jan Claassen, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Pageof 44